Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Receivables: 2019-2025

Historic Change in Receivables for Benitec Biopharma (BNTC) over the last 1 years, with Jun 2025 value amounting to $29,000.

  • Benitec Biopharma's Change in Receivables fell 83.52% to $29,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $25,000, marking a year-over-year decrease of 85.12%. This contributed to the annual value of -$197,000 for FY2025, which is 211.93% down from last year.
  • Per Benitec Biopharma's latest filing, its Change in Receivables stood at $29,000 for Q2 2025, which was up 112.83% from -$226,000 recorded in Q3 2024.
  • In the past 5 years, Benitec Biopharma's Change in Receivables ranged from a high of $176,000 in Q2 2024 and a low of -$226,000 during Q3 2024.
  • Moreover, its 2-year median value for Change in Receivables was $29,000 (2025), whereas its average is -$7,000.
  • Data for Benitec Biopharma's Change in Receivables shows a peak YoY increase of 757.14% (in 2022) and a maximum YoY decrease of 771.43% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows Benitec Biopharma's Change in Receivables stood at -$7,000 in 2021, then surged by 757.14% to $46,000 in 2022, then reached -$226,000 in 2024, then tumbled by 83.52% to $29,000 in 2025.
  • Its Change in Receivables was $29,000 in Q2 2025, compared to -$226,000 in Q3 2024 and $176,000 in Q2 2024.